SYRE SCHEDULE 13G/A: SEC filing
A Schedule 13G/A amendment was
Filed with the SEC on · accession 0001193125-26-352655
SYRE filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. A Schedule 13G/A amendment was filed regarding beneficial ownership of Spyre Therapeutics, Inc. common stock. The stock moved +1.7% by the first close after the filing.
Summary of the filing
A Schedule 13G/A amendment was filed regarding beneficial ownership of Spyre Therapeutics, Inc. common stock. The filing indicates a change in a holder's previously reported ownership position.
Key details
How SYRE stock reacted
Close before
$101.85
Aug 13, 2026
First close after
+1.75%
$103.63
5 trading days
+5.83%
$107.79
Since filing
+1.97%
$103.86
✦ Ask GOAX AI about this filing — what it means for SYRE, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for SYRE?
Click hereFrequently asked questions
What did SYRE file with the SEC on Aug 14, 2026?
SYRE filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding beneficial ownership of Spyre Therapeutics, Inc. common stock. The filing indicates a change in a holder's previously reported ownership position.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did SYRE stock react to this filing?
SYRE closed at $101.85 before the filing and $103.63 on Aug 14, 2026 (+1.75%). Five trading days later: $107.79 (+5.83%).
Other SYRE SEC filings
- 10-Q · SEC filingNov 3, 2026
- 8-K · SEC filingNov 3, 2026
- SCHEDULE 13D/A · SEC filingOct 9, 2026
- 8-K · Secondary offeringOct 7, 2026
- 424B5 · Secondary offeringOct 6, 2026
- 424B5 · Secondary offeringOct 5, 2026
- SCHEDULE 13G · SEC filingOct 1, 2026
- 8-K · SEC filingSep 8, 2026
- 8-K · SEC filingAug 25, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
Get alerts when SYRE files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days